CALB2 and major depressive disorder: Calretinin ↓ (in layer I in patients with major depressive disorder compared to control subjects) A significant correlation between reduced density of calretinin-immunoreactive in the dlPFC of patients with major depressive disorder and lower density or size of glial cells and pyramidal neurons in subjects from the Stanley Neuropathology Consortium